V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16664673 | 330023467 | EGT | 1 | null | 1 | 2014-03-14 | STEROID | 330021144 | 330002415 | 330005019 |
| 16664674 | 330023468 | EPH | 75 | null | 5 | 2017-01-06 | DOCETAXEL | 330021149 | 330007326 | 330005021 |
| 16664677 | 330023470 | ETG01 | 1400 | X721 | 1 | 2013-12-16 | GEMCITABINE | 330021193 | 330002420 | 330005029 |
| 16664678 | 330023470 | EKU09 | 1000 | null | 2 | 2013-12-16 | NOT CHEMO | 330021193 | 330002420 | 330005029 |
| 16664679 | 330023470 | EEX02 | 50 | X723 | 1 | 2013-12-17 | METHOTREXATE | 330021193 | 330002420 | 330005029 |
| 16664680 | 330023470 | EUDUU | 8 | null | 1 | 2013-12-18 | NOT CHEMO | 330021193 | 330002420 | 330005029 |
| 16664681 | 330023471 | ETG | 8 | X724 | 1 | 2016-01-22 | GEMCITABINE | 330021193 | 330002420 | 330005030 |
| 16664682 | 330023471 | EGU05 | 90 | null | 1 | 2016-01-22 | RITUXIMAB | 330021193 | 330002420 | 330005030 |
| 16664683 | 330023471 | EEX02 | 12000 | null | 1 | 2016-01-22 | METHOTREXATE | 330021193 | 330002420 | 330005030 |
| 16664684 | 330023471 | EKU01 | 38 | X724 | 2 | 2016-01-23 | NOT CHEMO | 330021193 | 330002420 | 330005030 |
| 16664685 | 330023471 | EOI | 1.6 | X723 | 1 | 2016-01-23 | CYCLOPHOSPHAMIDE | 330021193 | 330002420 | 330005030 |
| 16664686 | 330023471 | EOI | 1440 | null | 1 | 2016-01-23 | CYCLOPHOSPHAMIDE | 330021193 | 330002420 | 330005030 |
| 16664687 | 330023473 | EEI00 | 170 | X724 | 1 | 2016-10-10 | GEMCITABINE | 330021193 | 330002420 | 330005035 |
| 16664688 | 330023473 | EKD50 | 8 | null | 1 | 2016-10-17 | STEROID | 330021193 | 330002420 | 330005035 |
| 16664689 | 330023473 | EUDJC | 50 | X729 | 1 | 2016-10-17 | METHOTREXATE | 330021193 | 330002420 | 330005035 |
| 16664690 | 330023473 | EWR01 | 120 | X721 | 2 | 2016-10-17 | NOT CHEMO | 330021193 | 330002420 | 330005035 |
| 16664691 | 330023473 | ELW | 8 | X729 | 2 | 2016-10-17 | NOT CHEMO | 330021193 | 330002420 | 330005035 |
| 16664692 | 330023473 | ERA20 | 2 | null | 1 | 2016-10-17 | VINCRISTINE | 330021193 | 330002420 | 330005035 |
| 16664693 | 330023474 | EJRNN | 1200 | null | 5 | 2013-09-28 | GEMCITABINE | 330021193 | 330002420 | 330005036 |
| 16664694 | 330023474 | EGU05 | 1000 | null | 2 | 2013-09-28 | NOT CHEMO | 330021193 | 330002420 | 330005036 |
| 16664695 | 330023474 | EUDJC | 25600 | X724 | 1 | 2013-09-29 | METHOTREXATE | 330021193 | 330002420 | 330005036 |
| 16664696 | 330023475 | EXO | 100 | null | 1 | 2016-06-29 | DOCETAXEL | 330021193 | 330002420 | 330005037 |
| 16664697 | 330023476 | EEX02 | 1368 | X723 | 5 | 2015-06-30 | DOCETAXEL | 330021193 | 330002420 | 330005038 |
| 16664698 | 330023476 | EA541 | 1000 | null | 2 | 2015-07-01 | NOT CHEMO | 330021193 | 330002420 | 330005038 |
| 16664699 | 330023476 | Haqrsvarq | 50 | X729 | 1 | 2015-07-02 | METHOTREXATE | 330021193 | 330002420 | 330005038 |
| 16664700 | 330023478 | EOI | 950 | X724 | null | 2016-09-18 | DOCETAXEL | 330021284 | 330002424 | 330005047 |
| 16664701 | 330023478 | ELE16 | 10 | X722 | 2 | 2016-09-18 | NOT CHEMO | 330021284 | 330002424 | 330005047 |
| 16664702 | 330023478 | EXO | 8 | null | 1 | 2016-09-18 | METHOTREXATE | 330021284 | 330002424 | 330005047 |
| 16664703 | 330023479 | eke20 | 20 | null | 1 | 2014-08-03 | CYTARABINE | 330021287 | 330002425 | 330005051 |
| 16664704 | 330023479 | EKD50 | 550 | X722 | 1 | 2014-08-03 | RITUXIMAB BIOSIMILAR (TRUXIMA) | 330021287 | 330002425 | 330005051 |
| 16664705 | 330023479 | EUDJC | 18000 | null | 1 | 2014-08-03 | METHOTREXATE | 330021287 | 330002425 | 330005051 |
| 16664706 | 330023480 | eke20 | 100 | X729 | 1 | 2013-02-20 | CYTARABINE | 330021300 | 330012254 | 330005052 |
| 16664709 | 330023484 | EWR01 | 20 | null | 1 | 2017-09-12 | CYTARABINE | 330021317 | 330012701 | 330005060 |
| 16664710 | 330023484 | EKY01 | 2 | null | 2 | 2017-09-12 | STEROID | 330021317 | 330012701 | 330005060 |
| 16664711 | 330023484 | EUDJC | 50 | null | 1 | 2017-09-13 | METHOTREXATE | 330021317 | 330012701 | 330005060 |
| 16664712 | 330023484 | EW701 | 71 | null | 1 | 2017-09-14 | LIPOSOMAL DOXORUBICIN | 330021317 | 330012701 | 330005060 |
| 16664713 | 330023485 | EWR01 | 20 | null | 1 | 2013-12-12 | CYTARABINE | 330021317 | 330012701 | 330005061 |
| 16664714 | 330023485 | ea506 | 8 | X724 | 2 | 2013-12-13 | DOXORUBICIN | 330021317 | 330012701 | 330005061 |
| 16664715 | 330023486 | EWR01 | 100 | X721 | 1 | 2013-03-23 | CYTARABINE | 330021317 | 330012701 | 330005062 |
| 16664716 | 330023486 | EON | 25 | null | 1 | 2013-03-24 | RITUXIMAB | 330021317 | 330012701 | 330005062 |
| 16664717 | 330023486 | ELW | 50 | X729 | 1 | 2013-03-24 | METHOTREXATE | 330021317 | 330012701 | 330005062 |
| 16664718 | 330023486 | EW100 | 100 | X723 | 1 | 2013-03-24 | LIPOSOMAL DOXORUBICIN | 330021317 | 330012701 | 330005062 |
| 16664719 | 330023486 | EOI | 190 | X729 | 1 | 2013-03-24 | ETOPOSIDE | 330021317 | 330012701 | 330005062 |
| 16664720 | 330023486 | ERA20 | 800 | X723 | 1 | 2013-03-24 | CYCLOPHOSPHAMIDE | 330021317 | 330012701 | 330005062 |
| 16664721 | 330023486 | EKA | 4 | null | 2 | 2013-03-24 | STEROID | 330021317 | 330012701 | 330005062 |
| 16664722 | 330023487 | EWR01 | 20 | X721 | 1 | 2013-07-29 | CYTARABINE | 330021317 | 330012701 | 330005063 |
| 16664723 | 330023487 | ERZ21 | 10 | null | 1 | 2013-07-29 | NOT CHEMO | 330021317 | 330012701 | 330005063 |
| 16664724 | 330023487 | EUJ01 | 50 | X729 | 1 | 2013-07-29 | METHOTREXATE | 330021317 | 330012701 | 330005063 |
| 16664725 | 330023488 | Haqrsvarq | 20 | X724 | 1 | 2014-01-28 | CYTARABINE | 330021334 | 330002430 | 330005067 |
| 16664726 | 330023489 | EWR01 | 4 | X721 | 2 | 2017-04-11 | CYTARABINE | 330021342 | 330002432 | 330005070 |